2020
DOI: 10.1007/s43152-020-00006-9
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Spinal Cord CX3CL1/CX3CR1 Signalling in Chronic Pain

Abstract: Purpose of Review Chronic pain is a distressing condition that is ineffectively treated at present. In order to develop novel, more efficacious analgesics for chronic pain, a better understanding of the underlying mechanisms is required. Despite chronic pain initially being considered as a neurocentric process, the role of communication between immune cells and neurons has been shown to be essential to the modulation of chronic pain. In the spinal cord, chemokine-mediated communication between microglia and ne… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 48 publications
(63 reference statements)
0
6
1
Order By: Relevance
“…CX3CR1 is therefore known as the fractalkine receptor or G-protein coupled receptor 13 (GRP13). There is a vast body of literature that suggests a pro-nociceptive role of microglial CX3CR1 in spinal and supraspinal sites in chronic pain conditions [62; 88]. This is contrary to the association found in our study.…”
Section: Resultscontrasting
confidence: 99%
“…CX3CR1 is therefore known as the fractalkine receptor or G-protein coupled receptor 13 (GRP13). There is a vast body of literature that suggests a pro-nociceptive role of microglial CX3CR1 in spinal and supraspinal sites in chronic pain conditions [62; 88]. This is contrary to the association found in our study.…”
Section: Resultscontrasting
confidence: 99%
“…CX3CR1 is therefore known as the fractalkine receptor or G-protein coupled receptor 13 (GRP13). There is a vast body of literature that suggests a pro-nociceptive role of microglial CX3CR1 in spinal and supraspinal sites in chronic pain conditions [ 73 , 74 ]. This is contrary to the association found in our study.…”
Section: Resultsmentioning
confidence: 99%
“…Indeed, recent reviews on the topic of FKN and chronic pain discuss the advantages of using a non-promiscuous axis as a specific therapeutic target, supported by convincing preclinical evidence of the axis' role in animal models of pain. The preclinical data encourages the exploration of clinical conditions in patients, to support the axis' translation into clinical benefits ( 65 , 66 ).…”
Section: Direct Evidence Of Chemokines In Trigeminal Painmentioning
confidence: 99%
“…C-X3-C motif chemokine ligand 1 (CX3CL1), or fractalkine (FKN), belongs to the CX3C chemokine family and signals only through its receptor CX3CR1, contrary to other promiscuous chemokines. FKN is the only member of the CX3C subfamily of chemokines, and its involvement in chronic pain has been of interest as a therapeutic target ( 64 , 65 ). Indeed, recent reviews on the topic of FKN and chronic pain discuss the advantages of using a non-promiscuous axis as a specific therapeutic target, supported by convincing preclinical evidence of the axis' role in animal models of pain.…”
Section: Direct Evidence Of Chemokines In Trigeminal Painmentioning
confidence: 99%